Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular infliximab versus methylprednisolone for chronic or recurrent knee arthritis
NL-OMON24235Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Trial of infliximab and methylprednisolone in autoimmune arthritis (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Primary endpoint: recurrence or persistence of knee arthritis. Started Sep 2004; status: recruiting.
02
Drugs
infliximabmethylprednisolone
03
Conditions
autoimmune arthritis
Beyond the preview
Go deeper on NL-OMON24235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24235.